Bill Sponsor
House Bill 1781
116th Congress(2019-2020)
Payment Commission Data Act of 2019
Active
Active
Passed House on Oct 28, 2019
Overview
Text
Introduced
Mar 14, 2019
Latest Action
Oct 29, 2019
Origin Chamber
House
Type
Bill
Bill
The primary form of legislative measure used to propose law. Depending on the chamber of origin, bills begin with a designation of either H.R. or S. Joint resolution is another form of legislative measure used to propose law.
Bill Number
1781
Congress
116
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Republican
Georgia
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
California
Democrat
Illinois
Democrat
Massachusetts
Democrat
Minnesota
Republican
Missouri
Democrat
New Jersey
Democrat
New Jersey
Democrat
New Jersey
Republican
South Carolina
Republican
Tennessee
House Votes (1)
Senate Votes (0)
checkPassed on October 28, 2019
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H8526)
Summary

Payment Commission Data Act of 2019

This bill allows certain payment information relating to covered drugs under the Medicare prescription drug benefit and Medicaid to be disclosed to additional entities. Specifically, certain subsidy and rebate information, as reported by prescription drug plan sponsors and drug manufacturers, may be disclosed to the Medicare Payment Advisory Commission and the Medicaid and Children's Health Insurance Program (CHIP) Payment and Access Commission, in accordance with specified confidentiality restrictions.

Text (4)
October 29, 2019
October 28, 2019
October 28, 2019
March 14, 2019
Actions (18)
10/29/2019
Received in the Senate and Read twice and referred to the Committee on Finance.
10/28/2019
Motion to reconsider laid on the table Agreed to without objection.
10/28/2019
On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H8526)
10/28/2019
Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.(text: CR H8526)
10/28/2019
DEBATE - The House proceeded with forty minutes of debate on H.R. 1781.
10/28/2019
Considered under suspension of the rules. (consideration: CR H8526-8527)
10/28/2019
Ms. Schakowsky moved to suspend the rules and pass the bill, as amended.
10/28/2019
Placed on the Union Calendar, Calendar No. 205.
10/28/2019
Committee on Ways and Means discharged.
10/28/2019
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-257, Part I.
04/03/2019
Ordered to be Reported (Amended) by Voice Vote.
04/03/2019
Committee Consideration and Mark-up Session Held.
03/27/2019
Forwarded by Subcommittee to Full Committee by Voice Vote .
03/27/2019
Subcommittee Consideration and Mark-up Session Held.
03/15/2019
Referred to the Subcommittee on Health.
03/14/2019
Referred to the Subcommittee on Health.
03/14/2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
03/14/2019
Introduced in House
Public Record
Record Updated
Nov 1, 2022 6:02:34 PM